Subcutaneous glargine insulin
FPS-INSUPAR-2015-01
Approved small_molecule completed
Quick answer
Subcutaneous glargine insulin for Diabetes Mellitus is a Approved program (small_molecule) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Diabetes Mellitus
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed